These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 18022682)

  • 21. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.
    Gressner OA; Weiskirchen R; Gressner AM
    Clin Chim Acta; 2007 Jun; 381(2):107-13. PubMed ID: 17399697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial hepatectomy-induced regeneration accelerates reversion of liver fibrosis involving participation of hepatic stellate cells.
    Suárez-Cuenca JA; Chagoya de Sánchez V; Aranda-Fraustro A; Sánchez-Sevilla L; Martínez-Pérez L; Hernández-Muñoz R
    Exp Biol Med (Maywood); 2008 Jul; 233(7):827-39. PubMed ID: 18445764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin E in chronic liver diseases and liver fibrosis.
    Di Sario A; Candelaresi C; Omenetti A; Benedetti A
    Vitam Horm; 2007; 76():551-73. PubMed ID: 17628189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver slices as a model to study fibrogenesis and test the effects of anti-fibrotic drugs on fibrogenic cells in human liver.
    van de Bovenkamp M; Groothuis GM; Meijer DK; Olinga P
    Toxicol In Vitro; 2008 Apr; 22(3):771-8. PubMed ID: 18207697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications.
    Friedman SL
    Nat Clin Pract Gastroenterol Hepatol; 2004 Dec; 1(2):98-105. PubMed ID: 16265071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic liver injury, TGF-beta, and cancer.
    Bissell DM
    Exp Mol Med; 2001 Dec; 33(4):179-90. PubMed ID: 11795478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
    Gressner OA; Rizk MS; Kovalenko E; Weiskirchen R; Gressner AM
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1024-35. PubMed ID: 18505415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C. L. Oakley Lecture (1993). Cellular and molecular aspects of hepatic fibrosis.
    Burt AD
    J Pathol; 1993 Jun; 170(2):105-14. PubMed ID: 8345406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutical targets for revert liver fibrosis].
    García B L; Gálvez G J; Armendáriz B J
    Rev Med Chil; 2007 Jun; 135(6):783-91. PubMed ID: 17728907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver fibrogenic cells.
    Forbes SJ; Parola M
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):207-17. PubMed ID: 21497739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic fibrosis, stellate cells, and portal hypertension.
    Rockey DC
    Clin Liver Dis; 2006 Aug; 10(3):459-79, vii-viii. PubMed ID: 17162223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokines and fibrogenesis.
    Friedman SL
    Semin Liver Dis; 1999; 19(2):129-40. PubMed ID: 10422196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
    Guarino M; Tosoni A; Nebuloni M
    Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cellular mechanism in the fibrogenesis of liver fibrosis].
    You H; Sun YM
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):563-4. PubMed ID: 23227528
    [No Abstract]   [Full Text] [Related]  

  • 35. Transcriptional regulation of hepatic stellate cells.
    Mann J; Mann DA
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):497-512. PubMed ID: 19393271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactive nitrogen species switch on early extracellular matrix remodeling via induction of MMP1 and TNFalpha.
    Urtasun R; Cubero FJ; Vera M; Nieto N
    Gastroenterology; 2009 Apr; 136(4):1410-22, e1-4. PubMed ID: 19250650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis.
    Gressner AM; Bachem MG
    Semin Liver Dis; 1990 Feb; 10(1):30-46. PubMed ID: 2186487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrosis and cirrhosis reversibility - molecular mechanisms.
    Gieling RG; Burt AD; Mann DA
    Clin Liver Dis; 2008 Nov; 12(4):915-37, xi. PubMed ID: 18984474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis.
    Pinzani M; Gentilini P
    Semin Liver Dis; 1999; 19(4):397-410. PubMed ID: 10643625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver extracellular matrix in health and disease.
    Bedossa P; Paradis V
    J Pathol; 2003 Jul; 200(4):504-15. PubMed ID: 12845618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.